FDA approves Pfizer's drug for advanced breast cancer

FDA approves Pfizer's drug for advanced breast cancer


The U.S. Food and Drug Administration said on Tuesday it approved Pfizer Inc's drug for an advanced form of breast cancer tied to an inherited gene mutation. The logo of U.S. pharmaceutical corporation Pfizer Inc. is seen at a branch in Zurich, Switzerland October 2, 2018.



from Biotech News